Customs Proposes Major Change to Origin Rules
Client Alert | 2 min read | 08.18.08
Customs & Border Protection (CBP) has issued a proposed rule that, if implemented, will fundamentally change the way that importers must analyze and determine the country of origin of many imported goods. Under CBP's regulations, where an imported product is processed in or contains inputs from multiple countries, the country of origin is the last country in which a "substantial transformation" occurred. In most cases (other than for products imported subject to Free Trade Agreements like NAFTA that have their own origin regimes), the "substantial transformation" analysis is based on a case-by-case analysis of each product and manufacturing process. This structure allows importers to make the case -- on a product-by-product basis -- that a particular operation does (or does not) constitute a "substantial transformation." The proposed rule, however, would eliminate this ad hoc analysis in favor of a more objective "tariff shift" analysis. Under this structure, country of origin would be based on the tariff classification of the finished product and the extent to which the input materials and intermediate products "shift" from different tariff categories.
The "tariff shift" rules that CBP would apply were developed as part of the NAFTA negotiations, and they reflect the influence of large NAFTA stakeholders (including the automotive, textile, and steel sectors). As a result, in some instances and for some products, the result under the "tariff shift" approach to determining country of origin will be different from the result under CBP's traditional approach. For example, CBP has consistently ruled that "mere formulation" of a pesticide (i.e., the addition of carriers, solvents, and excipients to active ingredients) does not constitute a substantial transformation, and so the country of origin remains the country in which the active ingredient was manufactured even if the formulation takes place elsewhere. However, under the "tariff shift" approach, formulation often does result in the necessary "shift," and, as a result, the country of origin is the country of formulation even where the active ingredient was manufactured elsewhere.
If the proposed rule is implemented, all U.S. importers of products that feature multi-country processing will need to reconsider the origin of all such products in the context of the "tariff shift" approach and possibly adjust import declarations and country-of-origin marking accordingly.
Interested parties who wish to comment on the proposal must submit such comments on or before September 23, 2008. For more information, please contact Barry Cohen, Alex Schaefer, or Nicole Jenkins, and for a copy of the Notice of Proposed Rulemaking, go to http://edocket.access.gpo.gov/2008/pdf/E8-17025.pdf.
International Trade Group News
Crowell & Moring LLP is pleased to announce the addition of Daniel Cannistra as counsel in the firm's International Trade group. Dan's practice focuses on legislative, executive and regulatory representation of domestic and international clients on a broad spectrum of international trade matters. Please click to view Dan's full biography.
Contacts
Insights
Client Alert | 11 min read | 12.15.25
New York LLC Transparency Act: Key Requirements and Deadlines
On January 1, 2026 (“Effective Date”), the New York LLC Transparency Act ("New York Act”) is scheduled to take effect, introducing new disclosure requirements for limited liability companies (“LLCs”) formed or registered to do business in New York State. The New York Act is expected to impose the type of broad beneficial ownership requirements the federal CTA and rules implementing it was designed to require, before the federal government’s decision to limit the scope of the CTA’s beneficial ownership reporting requirements to foreign companies and foreign beneficial owners.
Client Alert | 7 min read | 12.15.25
The New EU “Pharma Package:” EU Reaches Landmark Deal on Pharma Package
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office

